Skip to content

13F-HR filed by BVF INC/IL

BVF INC/IL filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 30 holding rows worth $478,239,000.

Accession
0000921895-15-001376
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 30 entries on the cover page, a total value of $478,239,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $478,239,000 with VALUE read as thousands by filing date, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARRAY BIOPHARMA INC COM04269X105Stock9,405,817$69,321,000thousands by filing date
CHEMOCENTRYX INC16383L106COM8,303,084$62,688,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK2,171,108$34,738,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR1,177,481$33,346,000thousands by filing date
ONCOMED PHARMACEUTICALS INC COM68234X102Stock1,284,115$33,104,000thousands by filing date
EXELIXIS INC30161QAC8NOTE 4.250% 8/131,239,000$23,937,000thousands by filing dateprincipal
ONCOTHYREON INC682324108COM14,314,178$23,332,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW267,090$20,595,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM1,340,659$20,304,000thousands by filing date
TARGACEPT INC87611R306COM6,655,128$19,766,000thousands by filing date
VITAE PHARMACEUTICALS INC92847N103COM1,577,435$18,472,000thousands by filing date
QLT INC746927102COMMON STOCK4,149,862$16,226,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW2,106,989$14,285,000thousands by filing date
LOXO ONCOLOGY INC548862101COM1,125,665$14,015,000thousands by filing date
ARQULE INC04269E107COM6,174,561$13,831,000thousands by filing date
EXELIXIS INC COM30161Q104Stock4,988,357$12,820,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock502,832$11,490,000thousands by filing date
GTX INC40052B108COM11,111,111$7,508,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock391,424$6,601,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW1,893,030$4,638,000thousands by filing date
MAST THERAPEUTICS INC576314108COM7,241,600$3,512,000thousands by filing date
BIOLINERX LTD-SPONS ADR09071M106SPON1,501,000$3,167,000thousands by filing date
ONCOGENEX PHARMACEUTICALS IN68230A106COM1,368,500$2,942,000thousands by filing date
REGADO BIOSCIENCE INC75874Q107COM1,882,521$2,297,000thousands by filing date
ACHAOGEN INC004449104COM136,600$1,333,000thousands by filing date
MEI PHARMA INC55279B202COM NEW600,000$1,074,000thousands by filing date
APTOSE BIOSCIENCES INC COM03835T200Stock166,664$907,000thousands by filing date
BIOTA PHARMACEUTIALS INC090694100COM350,776$807,000thousands by filing date
SOPHIRIS BIO INC F83578Q209FOREIGN CANADIAN1,060,283$614,000thousands by filing date
KALOBIOS PHARMACEUTICALS INC48344T100COM1,162,000$569,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000921895-15-001376this filing2015-05-15acceptance time not in the bulk data set